Interestingly, in IBD patients, elevated serum IL-36α negatively correlated with levels of circulating IL-36Ra, indicating an environment permissive to enhanced IL-36R activation during the earliest stages of disease. This evidence concerns the gene IL1RL2 and inflammatory bowel disease.